Vimarsana
Biggest News Aggregation in the World

Page 20 - Ipca Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ipca Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ipca Labs Today - Breaking & Trending Today

Ipca Labs Q4 profit up 94 pc at Rs 161 cr - Vimarsana News

Ipca Labs Q4 profit up 94 pc at Rs 161 cr

Ipca Labs Q4 profit up 94 pc at Rs 161 cr Ipca Labs Q4 profit up 94 pc at Rs 161 cr New Delhi, May 28: Drug firm Ipca Laboratories on Friday reported 94.09 per cent rise in consolidated net profit at Rs 161.20 crore for March quarter 2020-21 mainly on account of higher sales and reduction in expenses. The company posted a net profit of Rs 83.05 crore for the same period a year ago, Ipca Labs said in a filing to BSE. Total income stood at Rs 1,134.58 crore in the quarter under review. It was Rs 1,087.49 crore in March quarter 2019-20, it added. Total expenses were Rs 939.95 crore in the quart...

Drug firm Ipca Laboratories fourth quarter profit up 94% at Rs 161 crore - Vimarsana News

Drug firm Ipca Laboratories fourth quarter profit up 94% at Rs 161 crore

Read more about Drug firm Ipca Laboratories fourth quarter profit up 94% at Rs 161 crore on Business Standard. Shares of Ipca Laboratories were trading at Rs 2,132.30 per scrip on BSE, down 3.06 per cent from the previous close.

Glenmark arm, Emcure, 3 other pharma cos line up Rs 7,000-cr IPOs - Vimarsana News

Glenmark arm, Emcure, 3 other pharma cos line up Rs 7,000-cr IPOs

Amidst the raging second wave of the COVID-19 pandemic and many fearing a third wave, the healthcare sector is in the limelight for the second consecutive year as several pharma and life sciences companies are lined up to tap the equity markets through IPOs over the next few months, according to investment bankers. Five such companies which have firmed up their initial public offering (IPO) plans are Glenmark Lifesciences, a fully-owned arm of Glenmark Pharmaceuticals, the city-based bulk drugs firm Supriya Lifesciences, drug formulations firm Windlass Biotech, Bain Capital-backed Emcure Ph...

Covid pushes India's Pharma industry growth to 59% in April - Vimarsana News

Covid pushes India's Pharma industry growth to 59% in April

Covid pushes India's Pharma industry growth to 59% in April ​ By IANS | ​ 2 Views India's pharma exports surge as tide turns against China Image Source: IANS News Despite the widespread use of oral contraceptives (OCPs) by women, many are not aware that it may impair their ability to recognise others' emotional expressions, which may have serious consequences in interpersonal contexts, suggests a new study. Image Source: IANS News New Delhi, May 15 : The fresh wave of Covid-19 in the country has pushed up sales of medicines and resulted in exponential growth for the pharmaceutical secto...

India's Pharma sector growth up 59 per cent - Vimarsana News

India's Pharma sector growth up 59 per cent

The fresh wave of Covid-19 in the country has pushed up sales of medicines and resulted in exponential growth for the pharmaceutical sector.